CHNC China Infrastructure Construct

China Infrastructure Construction Corp. (OTC: CHNC) www.thechnc.com Announces That it has Acquired Houston, TX-Based Hippocrates Direct Healthcare, Inc. as a Wholly-Owned Subsidiary, Through a Reverse Merger

China Infrastructure Construction Corp. (OTC: CHNC) Announces That it has Acquired Houston, TX-Based Hippocrates Direct Healthcare, Inc. as a Wholly-Owned Subsidiary, Through a Reverse Merger

CHNC Announces OTC Update and Subsidiary Acquisition

Houston, TX, July 24, 2018 (GLOBE NEWSWIRE) -- China Infrastructure Construction Corp. (OTC: CHNC) announces that it has acquired Houston, TX-based Hippocrates Direct Healthcare, Inc. as a wholly-owned subsidiary, through a reverse merger. We are also very excited to announce further that Elizabeth Hernández has accepted the position as President and CEO.

Elizabeth Hernández said: “I am ready for the challenges of running a multi-million dollar company. It is time to bring back direct access to your clinician. Technological advancements in point of care testing, and communications coupled with old-fashioned individual attention will be the solution to uncontrolled medical costs and poor quality healthcare. Direct access to physicians through text, talk, email, and in-person encounters will solve most of the problems plaguing America.”

The company will own and staff individual clinical facilities initially in the Houston Metro area and will expand nationwide.

About Hippocrates Direct Healthcare™

Hippocrates Direct Healthcare, Inc. is innovating healthcare by redefining the doctor-patient relationship. Direct access to physicians, by its clients, is the cornerstone of Hippocrates. It is understandable why patients and providers are both dissatisfied with the way medical care is delivered. From a patient’s perspective, medical care is a vast web of bureaucracy that is expensive, time consuming and lacking in considerations for patient care and comfort. The care provided is minimal, five to ten minutes per visit at best, and one to two problems per visit as well. As a result, quality of care and results are sorely lacking—this is the TRUE cause of the crisis we face in medical care today. Hippocrates Direct will correct this problem. Hippocrates Direct offers concierge medicine through its membership-based model. More information can be found online at

China Infrastructure's common stock trades on the OTC Markets under the symbol "CHNC."

Safe Harbor Statement

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.

Hippocrates Direct Healthcare™ and the Hippocrates Direct Healthcare™ logo are all trademarks or registered trademarks of Hippocrates Direct Healthcare™, Inc.

CONTACTS:

Investors:

Hippocrates Direct Healthcare™, Inc.

(346) 256-4695

Media:

EN
24/07/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Infrastructure Construct

 PRESS RELEASE

Cannabis Bioscience International Holdings Announces Effectiveness of ...

Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement HOUSTON, TX , Dec. 06, 2023 (GLOBE NEWSWIRE) -- via – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File No. 333-267039) (the “Registration Statement”), filed under the Securities Act of 1933 (the “Securities Act”), was declared effective by the United States Securities and Exchange Commission (the “SEC”) on December 5, 2023. This declaration does not imply that the SEC has approved or disapproved the offer or sal...

 PRESS RELEASE

Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebrandi...

Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website HOUSTON, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- via -- Cannabis Bioscience International Holdings (trading on the OTC Markets under the ticker symbol CBIH), a medical research company that specializes in clinical trials and cannabinoids education, proudly announces the launch of its new website as a part of its bold rebranding strategy. The new web page better represents the company’s values and vision, predominantly in the areas of research and production of cannabis as me...

 PRESS RELEASE

FINRA Announces Approval for Corporate Name Change From China Infrastr...

FINRA Announces Approval for Corporate Name Change From China Infrastructure Construction Corp. to Cannabis Bioscience International Holdings and Ticker Symbol Change from CHNC to CBIH HOUSTON, Texas, Aug. 21, 2023 (GLOBE NEWSWIRE) -- via -- Cannabis Bioscience International Holdings (the “Company”) a diversified medical and educational company with a particular focus on traditional clinical trials and cannabinoids research, is excited to announce that FINRA (Financial Industry Regulatory Authority, Inc.) has approved the corporate name change from “China Infrastructure Construction Corp...

 PRESS RELEASE

CBIH Announces the Completion of the “Phase of Research and Discovery"...

CBIH Announces the Completion of the “Phase of Research and Discovery" for Its Phytotherapy Cancer Scientific Project HOUSTON, TX, May 01, 2023 (GLOBE NEWSWIRE) -- via -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, announces the completion of the stage “research and discovery” on the strategic framework to develop future clinical trials of the effectiveness of cannabinoids in the treatment of Cancer. In this phase of target identification and validation, CBIH’s scientific team has developed molecular biology data analysis for exploring targets and biomark...

 PRESS RELEASE

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabi...

CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings HOUSTON, TX, April 24, 2023 (GLOBE NEWSWIRE) -- via -- CBIH, previously known as CHNC, and trading under the ticker symbol CHNC, today unveiled the rebranding of its identity, including a new logo as part of its strategy to better reflect CBIH’s focus, medical purpose, and vision for the future. Starting today, the company has officially begun the process of changing all its digital content, including old logos, websites, videos, advertising, products, and marketing descriptions. Th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch